Eliem Therapeutics Inc (NASDAQ:ELYM) has a beta value of -0.33 and has seen 1.11 million shares traded in the last trading session. The company, currently
During the last session, Eliem Therapeutics Inc (NASDAQ:ELYM)’s traded shares were 1.11 million, with the beta value of the company hitting -0.33. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
